XALKORI® 250 mg


Capsule
scheduling status
S4
registration number
47/26/0569
What XALKORI® 250 mg contains
Crizotinib.
other ingredients
Capsule contents Colloidal silicon dioxide Microcrystalline cellulose Anhydrous dibasic calcium phosphate Sodium starch glycolate Magnesium stearate Hard gelatin capsule Gelatin Titanium dioxide Red iron oxide (pink opaque shell) Printing ink Shellac Propylene glycol Black iron oxide.
Therapeutic classification
L01ED01.
© 2026 SAHPRA. ALL RIGHTS RESERVED